Article
Avita acquires MedExpress Pharmacy in North Carolina.
Avita acquires MedExpress Pharmacy in North Carolina.
Avita Pharmacy announced today the acquisition of MedExpress Pharmacy located in Salisbury, NC. MedExpress and Avita both offer specialty pharmacy services to patients with complex health conditions.
Founded in 1995, MedExpress has served patients in North Carolina, South Carolina, and Virginia with HIV, diabetes, infertility, and primary medical needs with exceptional customer service.
“Avita’s acquisition of MedExpress allows us to expand our presence in the Carolinas and Virginia while bringing enhanced market opportunities and expertise to MedExpress. We are very excited about our new East Coast acquisition and the opportunity to provide Avita’s High-Touch model to all patients, providers, and prescribers,” states Avita’s CEO & President, Jerry Purcell.
Avita’s experience and specialty pharmacy expertise will broaden MedExpress’s current offerings allowing it to provide more “high-touch”solutions to its patients and prescribers. Avita will bring to MedExpress a large portfolio of limited distribution drugs, access to exclusive specialty-pharmacy payer contracts, and several accreditations scheduled for completion by the end of 2014.
###
About Avita Pharmacy
Avita is a full service pharmacy providing oral and injectable drug therapies for HIV, Hepatitis C, Organ Transplantation, Mental Health, and other complex diseases. Since 2003, Avita Pharmacy has served patients primarily in Louisiana, Mississippi, and Texas with expanded services to patients in 15 other states through its locations in New Orleans, Dallas, San Antonio, and its corporate office in Baton Rouge, LA. Avita is also a veteran expert in 340B program administration providing solutions to eligible organizations across the country.
Avita’s patient-centered approach keeps patients adherent to medication therapy through free delivery, refill reminders, compliance packaging, financial assistance, benefits coordination, and a dedicated prior authorization department.
SOURCE: Avita Pharmacy
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa